ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics signs with Oxford Univ to validate test for Endo
|
|
Scotty01
|
4 |
1.7K |
6 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
4
|
1.7K
|
6
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: PromarkerD US commercialisation & Promarker pipeline update
|
|
Scotty01
|
63 |
20K |
2 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
63
|
20K
|
2
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: PromarkerD application for Australian MBS to be resubmitted
|
|
Scotty01
|
49 |
18K |
1 |
15/03/23 |
15/03/23 |
ASX - By Stock
|
49
|
18K
|
1
|
|
ASX - By Stock
|
ELO |
Re:
Ann: Scheme of arrangement becomes effective
|
|
Scotty01
|
4 |
2.1K |
0 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
4
|
2.1K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
Scotty01
|
64 |
22K |
0 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
64
|
22K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Wake up ASX market
|
|
Scotty01
|
14 |
7.8K |
0 |
28/03/22 |
28/03/22 |
ASX - By Stock
|
14
|
7.8K
|
0
|
|
ASX - By Stock
|
APT |
Re:
So what now?
|
|
Scotty01
|
48 |
53K |
1 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
48
|
53K
|
1
|
|
ASX - By Stock
|
APX |
Re:
Ann: Appen completes acquisition of Quadrant Global
|
|
Scotty01
|
118 |
43K |
0 |
18/09/21 |
18/09/21 |
ASX - By Stock
|
118
|
43K
|
0
|
|
ASX - By Stock
|
APX |
Re:
Ann: Appen completes acquisition of Quadrant Global
|
|
Scotty01
|
118 |
43K |
2 |
14/09/21 |
14/09/21 |
ASX - By Stock
|
118
|
43K
|
2
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Study shows diabetes drug improves PromarkerD risk scores
|
|
Scotty01
|
53 |
14K |
2 |
17/07/21 |
17/07/21 |
ASX - By Stock
|
53
|
14K
|
2
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Study shows diabetes drug improves PromarkerD risk scores
|
|
Scotty01
|
53 |
14K |
3 |
16/07/21 |
16/07/21 |
ASX - By Stock
|
53
|
14K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Update on study presented at ADA Conference
|
|
Scotty01
|
32 |
10K |
1 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
32
|
10K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Request for extension of voluntary suspension
|
|
Scotty01
|
26 |
4.8K |
1 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
26
|
4.8K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Pause in Trading
|
|
Scotty01
|
64 |
18K |
3 |
27/06/21 |
27/06/21 |
ASX - By Stock
|
64
|
18K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Pause in Trading
|
|
Scotty01
|
64 |
18K |
3 |
26/06/21 |
26/06/21 |
ASX - By Stock
|
64
|
18K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Pause in Trading
|
|
Scotty01
|
64 |
18K |
3 |
25/06/21 |
25/06/21 |
ASX - By Stock
|
64
|
18K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
Scotty01
|
322 |
93K |
2 |
04/06/21 |
04/06/21 |
ASX - By Stock
|
322
|
93K
|
2
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
Scotty01
|
322 |
93K |
1 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
322
|
93K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: ISO 13485 certification received - Manufacturing Update
|
|
Scotty01
|
19 |
5.6K |
1 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
19
|
5.6K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: ISO 13485 certification received - Manufacturing Update
|
|
Scotty01
|
19 |
5.6K |
0 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
19
|
5.6K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Exercise of Options
|
|
Scotty01
|
57 |
19K |
2 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
57
|
19K
|
2
|
|
ASX - By Stock
|
APT |
Re:
Ann: H1 FY21 Results Presentation
|
|
Scotty01
|
157 |
60K |
0 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
157
|
60K
|
0
|
|
ASX - By Stock
|
APX |
Re:
Appen, Entropy, DCF Models & Investor Behaviour
|
|
Scotty01
|
380 |
198K |
1 |
06/01/21 |
06/01/21 |
ASX - By Stock
|
380
|
198K
|
1
|
|
ASX - By Stock
|
APX |
Re:
Appen, Entropy, DCF Models & Investor Behaviour
|
|
Scotty01
|
380 |
198K |
0 |
06/01/21 |
06/01/21 |
ASX - By Stock
|
380
|
198K
|
0
|
|
ASX - By Stock
|
APX |
Re:
Appen, Entropy, DCF Models & Investor Behaviour
|
|
Scotty01
|
380 |
198K |
1 |
06/01/21 |
06/01/21 |
ASX - By Stock
|
380
|
198K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International raises $6m in successful Placement
|
|
Scotty01
|
35 |
8.0K |
4 |
23/10/20 |
23/10/20 |
ASX - By Stock
|
35
|
8.0K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Scotty01
|
13K |
4.9M |
0 |
29/09/20 |
29/09/20 |
ASX - By Stock
|
13K
|
4.9M
|
0
|
|
ASX - By Stock
|
CGF |
Re:
Challenger
|
|
Scotty01
|
77 |
32K |
0 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
77
|
32K
|
0
|
|
ASX - By Stock
|
CGF |
Re:
Challenger
|
|
Scotty01
|
77 |
32K |
0 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
77
|
32K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proposed issue of Securities - PIQ
|
|
Scotty01
|
4 |
1.9K |
1 |
18/08/20 |
18/08/20 |
ASX - By Stock
|
4
|
1.9K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Scotty01
|
13K |
4.9M |
0 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
13K
|
4.9M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Scotty01
|
203 |
89K |
0 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
203
|
89K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Scotty01
|
203 |
89K |
2 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
203
|
89K
|
2
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
Scotty01
|
77 |
21K |
0 |
12/06/20 |
12/06/20 |
ASX - By Stock
|
77
|
21K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: PromarkerD IVD successfully developed and validated
|
|
Scotty01
|
3 |
2.1K |
1 |
17/09/19 |
17/09/19 |
ASX - By Stock
|
3
|
2.1K
|
1
|
|
ASX - By Stock
|
EML |
Re:
Ann: Managing Director's AGM Presentation
|
|
Scotty01
|
21 |
9.8K |
0 |
10/09/19 |
10/09/19 |
ASX - By Stock
|
21
|
9.8K
|
0
|
|
ASX - By Stock
|
14D |
Re:
3 Options for Energy Storage
|
|
Scotty01
|
359 |
70K |
0 |
09/09/19 |
09/09/19 |
ASX - By Stock
|
359
|
70K
|
0
|
|
ASX - By Stock
|
14D |
Re:
Next opportunity for 14D
|
|
Scotty01
|
185 |
70K |
0 |
07/09/19 |
07/09/19 |
ASX - By Stock
|
185
|
70K
|
0
|
|
ASX - By Stock
|
TTT |
Re:
News: TTT Titomic Enters Agreement With FLSmidth
|
|
Scotty01
|
4 |
4.0K |
0 |
08/07/19 |
08/07/19 |
ASX - By Stock
|
4
|
4.0K
|
0
|
|
ASX - By Stock
|
14D |
Re:
14D Chart Thread
|
|
Scotty01
|
1.3K |
521K |
0 |
24/05/19 |
24/05/19 |
ASX - By Stock
|
1.3K
|
521K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Appendix 4C - March 2019 Quarterly Report
|
|
Scotty01
|
54 |
16K |
2 |
24/04/19 |
24/04/19 |
ASX - By Stock
|
54
|
16K
|
2
|
|
ASX - By Stock
|
14D |
Re:
Possible Future 1414 Projects upscaled
|
|
Scotty01
|
42 |
17K |
0 |
18/04/19 |
18/04/19 |
ASX - By Stock
|
42
|
17K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: PromarkerD US market update
|
|
Scotty01
|
38 |
12K |
1 |
26/01/19 |
26/01/19 |
ASX - By Stock
|
38
|
12K
|
1
|
|
ASX - By Stock
|
TTT |
Re:
Ann: Titomic Commences Phase II Defence Program with TAUV
|
|
Scotty01
|
10 |
4.7K |
0 |
07/12/18 |
07/12/18 |
ASX - By Stock
|
10
|
4.7K
|
0
|
|
ASX - By Stock
|
APT |
Re:
Ann: Successful Completion of $117 million Capital Raising
|
|
Scotty01
|
47 |
18K |
1 |
24/08/18 |
24/08/18 |
ASX - By Stock
|
47
|
18K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Diagnostics update- Pipeline yields potential new biomarkers
|
|
Scotty01
|
10 |
4.2K |
1 |
23/08/18 |
23/08/18 |
ASX - By Stock
|
10
|
4.2K
|
1
|
|
ASX - By Stock
|
ELO |
Re:
Ann: FY18 Full Year Results Presentation details
|
|
Scotty01
|
26 |
19K |
0 |
22/08/18 |
22/08/18 |
ASX - By Stock
|
26
|
19K
|
0
|
|
ASX - By Stock
|
TTT |
Re:
Titomic at Eurobike 2018
|
|
Scotty01
|
12 |
9.4K |
0 |
11/07/18 |
11/07/18 |
ASX - By Stock
|
12
|
9.4K
|
0
|
|
Charts
|
BUB |
Re:
BUB chart
|
|
Scotty01
|
2.9K |
1.5M |
0 |
26/06/18 |
26/06/18 |
Charts
|
2.9K
|
1.5M
|
0
|
|
ASX - By Stock
|
APT |
Re:
Alternative Metrics
|
|
Scotty01
|
4.9K |
2.7M |
2 |
16/06/18 |
16/06/18 |
ASX - By Stock
|
4.9K
|
2.7M
|
2
|
|